Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Short-Term Debt issuances (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Short-Term Debt issuances for 10 consecutive years, with $16.0 million as the latest value for Q1 2026.

  • Quarterly Short-Term Debt issuances fell 30.43% to $16.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $17.6 million through Jan 2026, down 25.7% year-over-year, with the annual reading at $17.6 million for FY2026, 25.7% down from the prior year.
  • Short-Term Debt issuances for Q1 2026 was $16.0 million at Usana Health Sciences, up from $1.6 million in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $23.0 million in Q4 2024, with the low at -$60.0 million in Q1 2022.
  • Average Short-Term Debt issuances over 5 years is -$514250.0, with a median of $643500.0 recorded in 2023.
  • Peak annual rise in Short-Term Debt issuances hit 2803.79% in 2024, while the deepest fall reached 79.47% in 2024.
  • Over 5 years, Short-Term Debt issuances stood at $500000.0 in 2022, then soared by 58.4% to $792000.0 in 2023, then surged by 2803.79% to $23.0 million in 2024, then tumbled by 93.04% to $1.6 million in 2025, then soared by 900.0% to $16.0 million in 2026.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods came in at $16.0 million, $1.6 million, and $23.0 million for Q1 2026, Q2 2025, and Q4 2024 respectively.